TGFB1 and hepatocellular carcinoma: For the first time, we provide evidence that isoviolanthin targets the TGF-β/Smad and PI3K/Akt/mTOR pathways to repress TGF-β1-induced EMT phenotypes in HepG2 and Bel-7402 HCC cells.